Low-Molecular-Weight Heparin
Speaker: Aspirin is acceptable thromboprophylaxis agent in trauma patients
TAMPA, Fla. — Aspirin as a thromboprophylaxis agent was noninferior to low-molecular-weight heparin for all-cause mortality in patients with extremity, pelvic or acetabular fractures.
Speaker: Aspirin is an acceptable thromboprophylaxis agent in orthopedic trauma patients
TAMPA, Fla. —Aspirin as a thromboprophylaxis agent was noninferior to low-molecular-weight heparin for all-cause mortality in patients with extremity, pelvic or acetabular fractures, presented results showed.
DOACs may prevent symptomatic VTE better than heparin after noncardiac surgery
For prevention of venous thromboembolism after noncardiac surgery, direct oral anticoagulants may be preferred over low-molecular-weight heparin, according to a systematic review and meta-analysis.
Nine important updates for World Thrombosis Day
World Thrombosis Day is observed Oct. 13.
Venous thromboembolism guidelines aim to clarify proper care in areas with ‘a lot of uncertainty’
Venous thromboembolism — which includes deep vein thrombosis and pulmonary embolism — causes up to 100,000 deaths annually in the United States and affects patients in numerous health care settings, regardless of age.